Standaard Boekhandel gebruikt cookies en gelijkaardige technologieën om de website goed te laten werken en je een betere surfervaring te bezorgen.
Hieronder kan je kiezen welke cookies je wilt inschakelen:
Technische en functionele cookies
Deze cookies zijn essentieel om de website goed te laten functioneren, en laten je toe om bijvoorbeeld in te loggen. Je kan deze cookies niet uitschakelen.
Analytische cookies
Deze cookies verzamelen anonieme informatie over het gebruik van onze website. Op die manier kunnen we de website beter afstemmen op de behoeften van de gebruikers.
Marketingcookies
Deze cookies delen je gedrag op onze website met externe partijen, zodat je op externe platformen relevantere advertenties van Standaard Boekhandel te zien krijgt.
Je kan maximaal 250 producten tegelijk aan je winkelmandje toevoegen. Verwijdere enkele producten uit je winkelmandje, of splits je bestelling op in meerdere bestellingen.
Thrombotic thrombocytopenic purpura (TTP) is a life-threatening disease caused by a deficiency in ADAMTS13 which in the acquired form is provoked by autoantibodies against this protease. The main objective of this work was to study the pathophysiologic and prognostic value of anti-ADAMTS13 antibodies in patients with acquired TTP. The surveyed antibody profile revealed the presence of mainly IgG followed by IgA and IgM antibodies. IgG1-4 and IgA ADAMTS13-specific immune complex (ICs) were detected. IgG4 was the most prevalent IgG subclass, present either as free antibody or as ICs. IgG antibodies in combination with high inhibitor titers at disease presentation were associated with persistence of undetectable ADAMTS13 activity in clinical remission. TTP patients with high IgG4 and undetectable IgG1 levels were more prone to relapse than patients with low IgG4 and detectable IgG1 levels suggesting that IgG4 could be a useful biomarker for identification of patients at risk of disease recurrence. The comprehensive characterization of anti-ADAMTS13 antibodies as well as circulating ADAMTS13-specific ICs may contribute to a better understanding of the mechanisms leading to acquired TTP